Skip to main content

Risk and mortality associated with febrile neutropenia in lung cancer patients.

Publication ,  Conference
Daniel, DB; Crawford, J; Kuderer, NM; Dale, DC; Lyman, GH
Published in: JOURNAL OF CLINICAL ONCOLOGY
2004

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

2004

Volume

22

Issue

14

Start / End Page

671S / 671S

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Daniel, D. B., Crawford, J., Kuderer, N. M., Dale, D. C., & Lyman, G. H. (2004). Risk and mortality associated with febrile neutropenia in lung cancer patients. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 22, pp. 671S-671S).
Daniel, D. B., J. Crawford, N. M. Kuderer, D. C. Dale, and G. H. Lyman. “Risk and mortality associated with febrile neutropenia in lung cancer patients.” In JOURNAL OF CLINICAL ONCOLOGY, 22:671S-671S, 2004.
Daniel DB, Crawford J, Kuderer NM, Dale DC, Lyman GH. Risk and mortality associated with febrile neutropenia in lung cancer patients. In: JOURNAL OF CLINICAL ONCOLOGY. 2004. p. 671S-671S.
Daniel, D. B., et al. “Risk and mortality associated with febrile neutropenia in lung cancer patients.JOURNAL OF CLINICAL ONCOLOGY, vol. 22, no. 14, 2004, pp. 671S-671S.
Daniel DB, Crawford J, Kuderer NM, Dale DC, Lyman GH. Risk and mortality associated with febrile neutropenia in lung cancer patients. JOURNAL OF CLINICAL ONCOLOGY. 2004. p. 671S-671S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

2004

Volume

22

Issue

14

Start / End Page

671S / 671S

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences